| Stages of dysfunctional decision-making in addiction |
25 |
| Neuroinflammation as a risk factor for attention deficit hyperactivity disorder |
20 |
| Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies |
20 |
| Neuroimmune signaling in alcohol use disorder |
20 |
| Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine |
19 |
| 21st century neurobehavioral theories of decision making in addiction: Review and evaluation |
18 |
| Revisiting inflammation in bipolar disorder |
15 |
| Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease |
15 |
| Clinical models of decision making in addiction |
14 |
| Reproducibility and replicability in zebrafish behavioral neuroscience research |
13 |
| Modeling the development of drug addiction in male and female animals |
11 |
| Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease |
11 |
| Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and neuroprotective activities |
11 |
| Age and impulsive behavior in drug addiction: A review of past research and future directions |
11 |
| Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression |
10 |
| Circuit-based frameworks of depressive behaviors: The role of reward circuitry and beyond |
10 |
| Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies |
9 |
| D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment |
9 |
| Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light |
8 |
| FGIN-1- an agonist at translocator protein 18 kDa (TSPO), produces anti-anxiety and anti-panic effects in non-mammalian models |
8 |
| Tolerance to hypothermic and antinoceptive effects of Delta 9-tetrahydrocannabinol (THC) vapor inhalation in rats |
8 |
| Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine |
8 |
| Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions |
8 |
| The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study |
8 |
| Different effects of caffeine on behavioral neurophenotypes of two zebrafish populations |
8 |
| Diet and Alzheimer's dementia - Nutritional approach to modulate inflammation |
8 |
| Organization of dopamine and serotonin system: Anatomical and functional mapping of monosynaptic inputs using rabies virus |
8 |
| Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine |
7 |
| Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling |
7 |
| The alpha 3-selective potentiator of GABA(A) receptors, KRM-II- reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats |
7 |
| Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice |
7 |
| P2Y receptors in neuropathic pain |
7 |
| Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801 |
7 |
| Addiction as a BAD, a Behavioral Allocation Disorder |
7 |
| Differences in decision-making as a function of drug of choice |
7 |
| Repeated administration of a selenium-containing indolyl compound attenuates behavioural alterations by streptozotocin through modulation of oxidative stress in mice |
7 |
| Nicotine increases fear responses and brain acetylcholinesterase activity in a context-dependent manner in zebrafish |
7 |
| Environmental enrichment facilitates cocaine abstinence in an animal conflict model |
6 |
| Heart rate variability in alcohol use: A review |
6 |
| Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core |
6 |
| Cannabinoids, interoception, and anxiety |
6 |
| Assessment of depression-like behavior and anhedonia after repeated cycles of binge-like ethanol drinking in male C57BL/6J mice |
6 |
| Effects of caffeine ingestion on the diurnal variation of cognitive and repeated high-intensity performances |
6 |
| Caffeine modulates voluntary alcohol intake in mice depending on the access conditions: Involvement of adenosine receptors and the role of individual differences |
5 |
| The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats |
5 |
| Adolescent but not adult ethanol binge drinking modulates ethanol behavioral effects in mice later in life |
5 |
| Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism |
5 |
| Menthol facilitates dopamine-releasing effect of nicotine in rat nucleus accumbens |
5 |
| Individual decision-making in the causal pathway to addiction: contributions and limitations of rodent models |
5 |
| Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development |
5 |
